Bright Minds Biosciences Inc.
Pharmaceutical company · Chicago, Illinois, United States · Nasdaq: DRUG
Bright Minds Biosciences Inc. is a pharmaceutical company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker DRUG. It has reported private securities offerings to the US SEC, most recently $35 million sold in a notice filed in 2024.
Bright Minds Biosciences at a glance
What does Bright Minds Biosciences do?
Private fundraising reported to the SEC
14 Form D notices; the most recent reported $34.6 million sold (2024).
Frequently asked questions about Bright Minds Biosciences
Where is Bright Minds Biosciences headquartered?
Bright Minds Biosciences Inc. is headquartered in Chicago, Illinois, United States.
What does Bright Minds Biosciences do?
Bright Minds Biosciences Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Bright Minds Biosciences a public company?
Yes. Bright Minds Biosciences Inc. trades on Nasdaq under the ticker DRUG.
When was Bright Minds Biosciences founded?
The earliest incorporation on record for Bright Minds Biosciences Inc. is in 2019, according to public company registers.
Similar companies
- MAIA Biotechnology, Inc.Chicago, Illinois, United States
- Xeris Pharmaceuticals IncChicago, Illinois, United States
- Exicure, Inc.Chicago, Illinois, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.